home · filing · 0001171520-21-000304
8-K filed July 15, 2021, 7:59 PM ET
ticker CLPT
CIK 0001285550
leadership
confidence high
sentiment neutral
materiality 0.30
ClearPoint Neuro appoints Lynnette C. Fallon to Board of Directors
ClearPoint Neuro, Inc.
Lynnette C. Fallon appointed to Board effective July 15, 2021; also joins Audit Committee.
Board size increased from six to seven members to accommodate the appointment.
Ms. Fallon is EVP, General Counsel & Secretary of Axcelis Technologies (ACLS) with over 20 years at that company.
Receives $40,000 annual retainer and an initial $120,000 equity grant (option + RSU) vesting in one year.
Will receive additional $120,000 equity grant after each annual meeting where she serves as a director.
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Lynnette C. Fallon
Director
CLPT ·
ClearPoint Neuro, Inc.
Effective 2021-07-15
Filed July 15, 2021, 7:59 PM ET
appointed Lynnette C. Fallon to fill the newly created directorship, effective immediately.
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 0.95
Lynnette C. Fallon was appointed as Director at ClearPoint Neuro, Inc..
Action appointed
Role Director
Exact text from the filing
appointed Lynnette C. Fallon to fill the newly created directorship, effective immediately.
View on SEC.gov
Source: SEC EDGAR
accession 0001171520-21-000304
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.